Type A γ-aminobutyric acid (GABA A ) receptors are pentameric ligand-gated ion channels and the main drivers of fast inhibitory neurotransmission in the vertebrate nervous system 1,2 . Their dysfunction is implicated in a range of neurological disorders, including depression, epilepsy and schizophrenia 3,4 . Among the numerous assemblies that are theoretically possible, the most prevalent in the brain are the α1β2/3γ2 GABA A receptors 5 . The β3 subunit has an important role in maintaining inhibitory tone, and the expression of this subunit alone is sufficient to rescue inhibitory synaptic transmission in β1-β3 triple knockout neurons 6 . So far, efforts to generate accurate structural models for heteromeric GABA A receptors have been hampered by the use of engineered receptors and the presence of detergents 7-9 . Notably, some recent cryo-electron microscopy reconstructions have reported 'collapsed' conformations 8,9 ; however, these disagree with the structure of the prototypical pentameric ligand-gated ion channel the Torpedo nicotinic acetylcholine receptor 10,11 , the large body of structural work on homologous homopentameric receptor variants 12 and the logic of an ion-channel architecture. Here we present a highresolution cryo-electron microscopy structure of the full-length human α1β3γ2L-a major synaptic GABA A receptor isoformthat is functionally reconstituted in lipid nanodiscs. The receptor is bound to a positive allosteric modulator 'megabody' and is in a desensitized conformation. Each GABA A receptor pentamer contains two phosphatidylinositol-4,5-bisphosphate molecules, the head groups of which occupy positively charged pockets in the intracellular juxtamembrane regions of α1 subunits. Beyond this level, the intracellular M3-M4 loops are largely disordered, possibly because interacting post-synaptic proteins are not present. This structure illustrates the molecular principles of heteromeric GABA A receptor organization and provides a reference framework for future mechanistic investigations of GABAergic signalling and pharmacology.
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Extended Data Figs. 1, 2a, b, Extended Data Table 1 , Supplementary Video 1). The analysis of reconstituted receptors by western blotting revealed minimal proteolysis of receptor subunits (Extended Data Fig. 2c ). Radioligand-binding assays demonstrated that the reconstituted receptor retains functional properties and allosteric interactions as expected in a membrane context 13 (Fig. 1f, Extended Data Fig. 2d ). The agonist GABA (γ-aminobutyric acid) enhances binding of a benzodiazepine, [ 3 H]flunitrazepam (Extended Data Fig. 2d ), whereas allosteric interactions between extracellular domains (ECD) and transmembrane domains (TMD) were confirmed by enhancement of the binding of the agonist [ 3 H]muscimol in the presence of the anaesthetic etomidate (Fig. 1f ). The α1 subunit-specific nanobody Nb38 7 , which was enlarged by fusion to the extracellular adhesin domain of Helicobacter pylori (HopQ) to generate the 'megabody' Mb Nb38 cHopQ (denoted Mb38 for simplicity; see Methods), was used to randomize the orientation of the GABA A receptor in ice and facilitate particle alignment.
Three-dimensional reconstruction of the α1β3γ2L-Mb38 complex led to a cryo-EM map at a nominal resolution of 3.2 Å, which enabled us to build models for the ECD and TMD of all GABA A receptor subunits, and for the nanobody domain of Mb38 ( Fig. 1 , Extended Data Figs. 1a, d-g, 3a-l, Supplementary Video 2). Intracellular domains, which are largely disordered in the absence of interacting post-synaptic proteins, could be only partially modelled (Extended Data Fig. 3m , Supplementary Video 2). The tri-heteromeric α1β3γ2L receptor has a five-fold quasi-symmetrical architecture throughout ( Fig. 1a-e ). The intact organization of the TMDs observed here ( Fig. 1 , Extended Data Fig. 3 ) is in marked contrast with previous electron microscopy reconstructions of GABA A receptors in detergent 8, 9 (Extended Data Fig. 4 ). Additional density, corresponding to the helical belt formed by the nanodisc MSP2N2 proteins and the enclosed lipid bilayer, surrounds the TMD (Fig. 1a, c) . Unlike the previously reported complex in the presence of excess Nb38 7 , here Mb38 was added at lower concentrations and is bound only at a single, presumably higher-affinity site: the α1 + /β3 − interface (we use the principal (+) and complementary (−) subunit annotation convention) in the receptor ECD ( Fig. 1a -e, Extended Data Fig. 5 , Supplementary Information).
N-linked glycans observed at the periphery of β3 (Asn80, β3 strand and Asn149, β7 strand) and γ2 (Asn208, β9 strand) subunits project into the extracellular environment ( Fig. 1a , b, d, e). By contrast, glycans linked to α1 subunits at Asn111 occupy the receptor vestibule and remain in an immature form, modelled here as Man 4 GlcNAc 2 units (in which Man is mannose; Extended Data Fig. 6a , b), as has been observed in other heteromeric GABA A receptor structures [7] [8] [9] . The arrangement of α1-subunit N-linked glycans probably serves to regulate receptor assembly and stoichiometry, limiting the number of α subunits per pentamer to a maximum of two 7, 8 . We propose that, together with the unique properties of subunit interfaces, this ensures an ordered assembly whereby an α1β3 dimer combines with an α1β3γ2L trimer to form a heteropentameric receptor 7, 8 (Extended Data Figs. 6, 7, Supplementary Information).
In addition to annular lipids on the extracellular side of the bilayer, which were modelled as phosphatidylcholine (POPC) moieties (Extended Data Fig. 8a ), we discovered distinct electron microscopy densities associated with the cytosolic side of α1 subunits within electropositively charged pockets ( Fig. 2a , b, Supplementary Videos 1, 2). The high quality of the electron microscopy map enables unambiguous assignment to phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5) P 2 , also known as PIP 2 ) ( Fig. 2a ), which was confirmed by all of our high-resolution, small-molecule-bound GABA A receptor structures 14 . The inositol-1,4,5-trisphosphate (InsP3) head groups form extensive interactions with the protein backbone, as well as with charged and polar residues on the α1 M3 (Lys312 and Arg313) and M4 helices (Ser388, Ser390 and Lys391; Fig. 2c, d ). Sequence alignment reveals strict conservation of these residues among α subunits of synaptic-type GABA A receptors ( Fig. 2e , Extended Data Fig. 8b ). The InsP3 phosphate group at position 1 is also coordinated by the side chain of Arg249 protruding from the α1 M1-M2 loop ( Fig. 2c, d ). This loop directly affects receptor desensitization 15, 16 , and arginine residues at this position are conserved among the synaptic α-subunits (α1-α3, α5) or replaced by lysine residues in extrasynaptic α-subunits (α4, α6) ( Fig. 2e ). PIP 2 , an important component of the inner leaflet of plasma membranes, might have two functional roles in GABA A receptors. First, it might directly regulate channel function 17 , as it does in inwardly rectifying potassium channels 18 . Second, it might be involved in the internalization of synaptic-but not extrasynaptic-receptors. To test the first hypothesis, we performed inside-out patch-clamp electrophysiology on the same cell line used in the structural studies. Because receptors expressed on HEK293 cells were probably pre-bound to endogenous PIP 2 , we assessed the effects of PIP 2 depletion on currents evoked by the allosteric activator etomidate. The PIP 2 scavenger polyl-lysine 17 elicited a small enhancement in peak-current amplitudes (Extended Data Fig. 8c, d ). Previous studies that assessed the effect of PIP 2 depletion on steroidal modulation of GABA A receptors also did not reveal a functional effect on channel gating 19 . Therefore, we speculate that PIP 2 has roles in regulating receptor trafficking, rather than in modulating the channel function.
The agonist GABA binds at the two interfaces between adjacent β + and α − subunits (Extended Data Fig. 9a ). Although our structure was solved in the absence of exogenous GABA, we observe serendipitous Letter reSeArCH non-protein densities at the agonist-binding sites of both β + /α − interfaces (Extended Data Fig. 9b , c). Here, in contrast to competitiveantagonist-bound structures 14 , these sites adopt compact 'aromatic-box' configurations, lined by side chains of Phe200 and Tyr205 from the loop-C on the β + side and Phe46 and Phe65 on the α − side (Fig. 3a, b) , as is commonly observed across pentameric ligand-gated ion channels 12 . Although we cannot reliably determine the identity of the contaminating ligand, we carried out in silico molecular docking of GABA within these sites. The most energetically favourable conformation (with an estimated free energy of binding of −6.4 kcal mol −1 ) is that in which the ligand is coordinated primarily via hydrophilic interactions ( Fig. 3a, b , Extended Data Fig. 9d ). In each site, the α − Arg67 guanidinium moiety coordinates the GABA carboxylate ( Fig. 3a, b ). In this conformation-matching those we determined experimentally in GABA/benzodiazepine and GABA/picrotoxin α1β3γ2L complexes 14 -the GABA amino group forms cation-π interactions with Tyr205 ( Fig. 3c, d) . Substitution experiments in β2-containing receptors corroborate the importance of interactions identified by docking and their effects on GABA sensitivity 20 . Despite differences in detail ( Fig. 3 ), this GABA-binding mode is broadly consistent with those proposed recently for α1β1γ2 and α1β2γ2 heteromers 8,9 . Superposition of complementary-subunit ECDs illustrates structural distinctions between the agonist-binding sites of the β + /αinterfaces and analogous sites at other interfaces (Extended Data Fig. 9f ). The loops-C at the α + /βand α + /γinterfaces, and to a lesser extent the γ + /β − interface, protrude marginally further into the corresponding pockets than do the loops-C of the β + /αinterface. Although there is a general conservation of residue type, the loss of critical interactions (β3 + Phe200 replaced in α1 by Ser205, and in γ2 by Thr215; α1 − Arg67 replaced in β3 by Gln64, and in γ2 by Ala79) prevents agonist binding outside of canonical β + /α − sites. Accordingly, docking experiments at the α + /β − , α + /γ − and γ + /β − interfaces found that GABA binding was less favoured energetically (−5.5, −5.2 and −4.8 kcal mol −1 , respectively; Extended Data Fig. 9e ) than at the β + /α − interfaces.
The α1β3γ2L TMD region is fully ordered, and its five-fold symmetry is broken only by inherent sequence variations between subunit types. This is markedly different to some truncated heteromeric GABA A receptor structures solved in detergent (Extended Data Fig. 4 ), in which the pore is collapsed (Extended Data Fig. 4o -r) causing longrange receptor damage 8, 9 . The TMD forms the ion channel and has an electropositive ring at its cytosolic portal, a determinant of ionic selectivity in pentameric ligand-gated ion channels 12, 21 (Fig. 4a ).
Relative to the central vertical axis, M2 helices tilt outwards by about 9-11° ( Fig. 4c, d) . As in the cryo-EM structures of diazepam-bound and alprazolam-bound α1β3γ2L, GABA A R β3, chimeric GLIC-GABA A R_α1 and GABA A R_β3-α5 14, [22] [23] [24] , the tightest pore constriction is observed at the level of the desensitization gate (−2ʹ Pro/Ala) 15 , with a radius of 1.45 Å ( Fig. 4b-d ). At the activation-gate level, the 9ʹ Leu side chains are rotated away from the channel lumen compared to the bicuculline-bound α1β3γ2L structure 14 , and the pore radius is 2.38 Å ( Fig. 4b-d ). Given that the Pauling radius of a dehydrated chloride ion is 1.8 Å, the structure of the channel therefore defines a closed, non-conducting state. The concept of distinct hydrophobic gates controlling transitions between resting, active and desensitized states has been extensively studied at GABA A receptors and homologous receptors 15, 25, 26 . Here, the principal impediment to the flow of ions is formed by the cytoplasmic desensitization gate; our structure thus illustrates a desensitized channel conformation. The M1, M3 and M4 α-helices define binding sites for a range of compounds, including neurosteroids and general anaesthetics 22, 23, 27 . The β + /α − interface has been extensively studied with regard to binding and modulation by anaesthetics and alcohol 2, 27 . Accordingly, at this interface we observe a binding cavity lined by residues identified in photolabelling studies with anaesthetic derivatives 28 and by Asn265 (β3 15ʹ M2), the mutation of which strongly reduces sensitivity to propofol and etomidate 29 (Fig. 5a, b ). Additionally, transmembrane residues labelled by the barbiturate photolabels mTFD-MPAB or mTFD-MPP 27,30 map to a cavity formed at the γ2 + /β3 − interface, lined at the back by γ2 Ser280 (15ʹ M2) ( Fig. 5c, d) . By contrast, the α1 + /γ2 − interface appears to be locked by a continuous network of interactions, which are primarily hydrophobic (Extended Data Fig. 6f ). This is consistent with the α + /γ -TMD interface remaining an 'orphan site' thus far, with respect to receptor pharmacology 27 .
Although sequence analyses do not predict substantial secondary structure in the intracellular domain for GABA A receptor subunits, this region is known to act as a scaffold for auxiliary proteins 16, 31 . We observed protein density extending from the intracellular ends of the M3 and M4 helices; this was most noticeable for the α1 subunits, where we were able to model part of the post-M3 (Arg313-Val323) and pre-M4 regions (Thr385-Ser390; Extended Data Fig. 9g, h) . Beyond their contribution to the PIP 2 -binding sites described above, the α1post-M3 regions extend towards the neighbouring β3 + subunits, where interactions between α1 Trp317, β3 Phe307 and β3 Pro311 further enhance the stability of β + /αinterfaces (Extended Data Fig. 9g, h) .
We present here the first structure, to our knowledge, of a GABA A receptor in a lipid bilayer. The agonist-binding site and the ECD adopt activated conformations, while the ion channel resides in a nonconducting, desensitized state. Notably, this structure is different to those of related GABA A receptors reported recently in the presence of detergents, which appear to considerably affect inter-and intrasubunit interfaces 8, 9 . We also report an α-subunit-specific interaction between the GABA A receptor and inner-leaflet lipid PIP 2 , which merits a detailed investigation in follow-up studies. In a physiological context, this interaction may serve to sequester receptors to specific lipid microdomains, where receptor trafficking can be precisely regulated. This hypothesis draws parallels with the proposed coupling of the Torpedo nAChR and cholesterol-rich microdomains 32 . Our results open avenues for future functional and structural studies of GABA A receptor modulation by lipids and small molecules-such as anaesthetics and barbiturates-that target the transmembrane domain.
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MEthodS Data reporting. No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. GABA A receptor expression and purification. Human α1β3γ2L receptors were expressed using a stable tetracycline-inducible HEK293 cell line 13 adapted to suspension culture. The cell line was not authenticated or tested for mycoplasma contamination. In brief, the cell line comprises the full-length human α1 (Uniprot ID: P14867), β3 (Uniprot ID: P28472) and γ2L (Uniprot ID: P18507-2; 'long' isoform) genes, each under individual antibiotic selection. For purification purposes a Flag-tag was inserted at the N terminus of the α1 subunit and a (GGS) 3 GK-1D4 tag inserted at the C terminus of the γ2L subunit. Cells were grown in suspension in Freestyle293 medium supplemented with fetal bovine serum (Invitrogen) and selection antibiotics (geneticin, hygromycin-B, zeocin and blasticidin) at 37 °C and 8% CO 2 . At a cell density of about 1.5-2 × 10 6 cells per ml expression was induced by addition of doxycycline and sodium butyrate (Sigma-Aldrich) at 5 mM to enhance expression. Cells were collected by centrifugation after about 36 h. Cell pellets from around 1 l of suspension culture were resuspended in 20 mM HEPES pH 7.2, 300 mM NaCl and 1% (v/v) mammalian protease inhibitor cocktail (Sigma-Aldrich). For solubilization, a 10% (w/v) solution of lauryl maltose neopentyl glycol (LMNG, Anatrace) and cholesterol hemisuccinate (Anatrace) was prepared at a 10:1 molar ratio, respectively, and added at 1% (v/v) to the cell suspension. Cells were solubilized for around 1.5 h at 4 °C, and cell debris and insoluble material was removed by centrifugation (10,000g, 30 min). The supernatant was incubated with 1D4 affinity resin 22 with gentle mixing at 4 °C for about 2 h. Resin was recovered by centrifugation and washed extensively with buffer (20 mM HEPES pH 7.2, 300 mM NaCl) containing 0.1% (v/v) LMNG before on-bead reconstitution into nanodiscs. Nanodisc reconstitution. MSP2N2 (Addgene ID: 29520) was expressed and purified from Escherichia coli as previously described 33 . Owing to the tendency of detergent-purified receptors to aggregate upon elution, α1β3γ2L receptors were incorporated into nanodiscs while attached to 1D4 resin. In brief, receptors attached to 1D4 resin were mixed with around 1 bed volume of buffer containing POPC (Avanti; prepared as a 10 mg ml −1 stock in 3% n-dodecyl-β-d-maltoside, DDM, Anatrace; to a final POPC concentration of around 1.2 mM) supplemented with bovine brain extract (Sigma-Aldrich; Type I, Folch Fraction I; prepared as a 20 mg ml −1 stock in 3% DDM) at 4 °C for about 0.5 h. Lipids were added at a relative ratio of 85:15 POPC:brain extract. Excess lipids were removed by centrifugation before addition of an excess of MSP2N2 (around 0.6 mg ml −1 final concentration) to the receptor-bound resin-lipid mixture. The mixture of receptor-bound resin and MSP2N2 was pre-mixed gently at 4 °C for about 0.5 h before addition of Bio-Beads SM2 (around 60 mg ml −1 ; Bio-Rad) to initiate reconstitution. At this point the mixture was incubated at 4 °C for around 4 h with constant rotation. The resin/Bio-Bead mixture was recovered by centrifugation and washed extensively to remove empty nanodiscs; first with 20 mM HEPES pH 7.2, 300 mM NaCl, next with 10 mM HEPES pH 7.2, 150 mM NaCl and finally with 10 mM HEPES pH 7.2, 100 mM NaCl. Bound receptor-nanodisc complexes were eluted by addition of 1 mM 1D4-peptide in final wash buffer at 4 °C for around 16 h. The mixture was applied to an EconoPac column (Bio-Rad) to remove Bio-Beads and resin, and the receptor-nanodisc complex was transferred to a 100-kDa Amicon Ultra concentrator (Millipore) and concentrated to 0.5 mg ml −1 for cryo-EM grid preparation. Sample monodispersity was assessed by analytical size-exclusion chromatography on a Shimadzu HPLC system and by negative-stain electron microscopy. On the basis of this analysis, further purification of the sample before grid preparation was not required. Western blot analysis of cell lysates and purified receptors was performed using the following primary antibodies: rabbit anti-GABA A α1 (Millipore, 06-868), mouse anti-GABA A β2/3 (Millipore, MAB341) and mouse anti-GABA A γ2 (Synaptic Systems, 224003). Immunoreactivity was detected with secondary antibodies conjugated to horseradish peroxidase. Generation of Mb38. Megabodies (Mbs) are rigid antibody chimaeras, built from nanobodies (Nbs) that are grafted onto large scaffold proteins (J.S., manuscript in preparation). The particular construct used here, Mb Nb38 cHopQ (denoted Mb38), is a circular permutant of the extracellular adhesin domain of H. pylori (HopQ, UniProt B5Z8H1) 34 , which was inserted into the first β-turn connecting β-strands A and B of Nb38 7 . Specifically, the Mb38 open reading frame contains the DsbA leader sequence, followed by a consensus sequence encoding the conserved β-strand A of the nanobody fold (residues 1-13), followed by the C-terminal part of HopQ (residues 227-449), followed by a three-residue linker connecting the C and the N termini of HopQ, followed by the N-terminal part of HopQ (residues 49-221). The construct has C-terminal His 6 and EPEA tags in frame for affinity purification. Mb38 is monomeric, with a molecular weight of around 58 kDa. Similar to Nbs, Mb38 was expressed as a secreted protein in the periplasm of E. coli WK6 bacteria and purified using nickel-affinity chromatography followed by size-exclusion chromatography on a Superdex 200 16/60 column (GE Healthcare) in 10 mM Tris, pH 7.3, 140 mM NaCl. The stock solutions were concentrated to 15 mg ml −1 , snap-frozen in liquid nitrogen and stored at −80 °C. Cryo-EM sample preparation. Purified α1β3γ2L-nanodisc complexes at 0.5 mg ml −1 were mixed with Mb38 (at 1.2 μM) and incubated on ice for 0.5 h before cryo-EM grid preparation. Sample (3.5 μl) was applied to glow-discharged gold R1.2/1.3 300 mesh UltraAuFoil grids (Quantifoil) before blotting for 5 s at around 100% humidity and 14 °C, and then plunge-frozen into liquid ethane using a Vitrobot Mark IV (FEI). Cryo-EM image collection and processing. Data from a single grid were collected over two 24-h sessions on a FEI Titan Krios (Thermo Fisher) operated at 300 kV and equipped with a Falcon 3EC direct-detector and Volta phase plate. A total of 784 micrographs was collected in electron-counting mode at a nominal magnification of 75,000, corresponding to a calibrated pixel size of 1.07 Å. Each micrograph was collected as a 60-s exposure, comprising 75 movie frames at a dose rate of 0.55 electrons per pixel per second for a total accumulated dose of 30.84 e − Å −2 . Drift correction, beam-induced motion and dose-weighting were performed with MotionCor2 35 using a 5 × 5 patch. Contrast transfer function (CTF) fitting and phase-shift estimation were performed on motion-corrected sums without dose weighting with Gctf-v.1.18 36 . Micrographs were manually checked and a total of 737 micrographs (motion-corrected sums with dose weighting) used for all other image processing. An initial round of auto-picking on small subset of micrographs was performed in RELION 2.1 37 using a Gaussian blob as a template. Picked particles were subjected to reference-free 2D classification and good classes used for auto-picking on the entire dataset. Auto-picked particles were manually inspected and false positives removed, resulting in a total of 370,757 particles. Particles were 2 × binned (pixel size 2.14 Å) for initial processing. Two rounds of 2D classification were carried out in RELION 2.1 and 197,673 particles within classes exhibiting recognizable GABA A receptor channel features were selected for further processing. An initial 3D reference model was generated in RELION and low-pass-filtered to 50 Å. Three-dimensional classification into six classes resulted in four good classes (106,039 particles) and two classes comprising principally top and bottom views of the receptor-Mb38 complex. Particles from the four best classes were combined, re-extracted (1.07 Å pixel) and refined in RELION 2.1. Particle polishing (RELION 2.1) and CTF-Refine (RELION 3.0) further improved the resolution of the initial reconstruction. A second round of 3D classification, with no image alignment, yielded a single class containing 55,449 particles. Three-dimensional refinement of this class yielded a reconstruction at 3.75 Å before post-processing. Applying a soft mask in RELION post-processing yielded a final electron microscopy map of 3.22 Å. Notably, the calculated soft mask also accounted for density contributed by the nanodisc. Resolution was estimated using the Fourier shell correlation (FSC) = 0.143 criterion. Local resolution was calculated using the MonoRes implementation in Scipion 38, 39 . Model building, refinement and validation. An initial rigid-body fit of coordinates for the truncated α1β3γ2 (ref. 7 ) was carried out using UCSF Chimera 40 . Owing to the improved resolution of the reconstruction and apparent stability of the receptor complex in the nanodisc, a complete model of the receptorincorporating nearly all residue side chains-could be built with high accuracy in local geometry. The model was first manually adjusted and refined using Coot 41 and then subjected to global refinement and minimization in real space using PHENIX ('phenix.real_space_refine') 42 . Geometric constraints for lipids were generated using GradeServer (Global Phasing) and the ligand coordinates docked into densities and refined using Coot 41 .
The ECD and TMD regions in all subunits were well-resolved in the electron microscopy density map, as were Mb38 and the N-linked glycans. However, the HopQ scaffold protein fused to Mb38 was comparatively flexible, with no apparent electron microscopy density in the final reconstruction. Although density contributed by the nanodisc was evident in the electron microscopy reconstruction, the resolution did not permit modelling of the helical belt formed by MSP2N2 scaffold proteins. The final construction enabled unambiguous assignment of α1, β3 and γ2 subunits and main-chain and side-chain model building. Strong density was observed protruding from the 'intracellular' side of the nanodisc proximal to the α1 subunit TM3 and TM4 helices. We modelled this as approximately 10 residues of the M3-M4 loop of the α1 subunit. Strong density, unaccounted for by the protein backbone, was also apparent at the base of α1 TM3 and M4 helices. This was modelled as PIP 2 on the basis of its characteristic shape and orientation at the inner leaflet of the lipid bilayer. Additional density in the 'extracellular' layer of the nanodisc was modelled as POPC moieties. Cryo-EM map densities observed within the ion channel and in the (pseudo-)agonist sites were not modelled as we could not reliably determine the identity of a bound ligand.
During model building and refinement, model geometry was assessed using MolProbity 43 . For cross-validations, the final model was refined against the half maps generated by 3D auto-refine in RELION. Subunit interfaces and associated free energies were analysed using the PDBePISA server 44 . Pore diameters were calculated using the HOLE implementation in Coot. Structural figures were Letter reSeArCH prepared using UCSF Chimera 40 and PyMOL (Schrodinger), including the APBS 45 electrostatics plugin. Structural alignments were performed using the Superpose command in CCP4mg 46 or MatchMaker 40 . Tunnel-radii calculations were carried out using the Caver plugin 47 in PyMOL.
Density maps shown in figures were contoured at the following levels. Figure 1 : sharpened maps for the receptor and glycans contoured at 0.03; Fig. 2a : density around PIP 2 at 0.021; Extended Data Fig. 3a -c: subunits, density maps contoured at 0.03; Extended Data Fig. 3d , e: glycans, density maps contoured at 0.025; Extended Data Fig. 3f-h : loop-C, density maps contoured at 0.03; Extended Data Fig. 3i -k: TM helices, density maps contoured at 0.03; Extended Data Fig. 3l : density maps contoured at 0.03. Extended Data Fig. 3m : density maps contoured at 0.02. Extended Data Fig. 8a : density map contoured at 0.02. Extended Data Fig. 9b : density map contoured at 0.045. Computational docking. Computational docking of small molecules to GABA A receptor cryo-EM structures was performed using AutoDock Vina 48 . Structures of small molecules were optimized using Grade webserver (Global Phasing). The GABA A receptor was kept rigid during docking. The whole agonist-binding pocket (approximately 20 × 20 × 20 Å 3 ) centred under the loop-C was selected for docking. Electrophysiology. HEK 293 cells stably transfected with tetracycline-inducible human (N)-Flag-α1β3γ2L-(GGS)3GK-1D4 GABA A 49 were grown on glass coverslips, and expression was induced by 0.1-2 μg ml −1 doxycycline for 14 to 28 h depending on the level of current required. For pulling inside-out macro-patches, we used poly-l-lysine-coated glass coverslips (Becton Dickinson). Cells were also treated with kifunensine (5 μg ml −1 ) at the time of induction.
Currents were recorded in either whole-cell or inside-out configuration of patch clamp as previously described 50 using an Axopatch 200A amplifier (Molecular Devices). Ligands were applied via a quad-channel super-perfusion pipette coupled to a piezoelectric element that switched the super-perfusion solution in <1 ms as previously described 51 . Data were acquired using Clampex 8.2 (Molecular Devices). Data were acquired at either 10, 5 or 2 kHz and filtered at 5, 2 or 1 KHz, respectively, depending on the duration of the pulse: the longer the recording, the slower the data acquisition rate. Cells were continually perfused with a bath solution consisting of (in mM): 145 NaCl, 5 KCl, 10 HEPES, 2 CaCl 2 , 1 MgCl 2 and 10 glucose, pH 7.4 (adjusted with NaOH). The pipette solution consisted of (in mM): 140 KCl, 10 HEPES, 1 EGTA, 2 MgCl 2 and 2 Mg-ATP, pH 7.3 (adjusted with KOH). For whole-cell recordings, the open pipette resistances ranged from 1.3-2.5 MΩ, cell capacitance ranged from 5-13 pF and series resistance ranged from 0.2-2.5 MΩ. Series resistances were electronically compensated by >85% with a lag of 10 μs. The liquid junction potential between the bath and pipette solution was −2 mV and was corrected post-recording. Cells and patches were voltage-clamped at −52 mV. For inside-out patches, the solutions were reversed; that is, the pipettes were filled with the bath solution and the patches were perfused with the pipette solution. The pipette resistance for inside-out patches ranged from 4-6 MΩ. In all patch protocols, initially currents were repeatedly elicited with pulses of etomidate until stable currents were obtained before proceeding with the application of modulatory agents as described in the figure legend. For analysis, 2-5 identical traces from the same patch were averaged, and the ones before the patch was stabilized were disregarded. The peak-current amplitudes obtained with inside-out patches ranged between 7 and 44 pA. Electrophysiology data analysis. Current traces were analysed using Clampfit 9.0 (Molecular Devices). Statistical analysis (paired or unpaired Student's t-test) was done in GraphPad Prism 6 (GraphPad Software). P < 0.05 was considered statistically significant. Data are shown as mean ± s.d. Each n represents a different patch or cell. Current traces were normalized in Origin 6 for presentation. The enhancement data for Mb38 was fitted by nonlinear least squares in Igor Pro (Wavemetrics). Radioligand binding. The functionality of the receptors reconstituted in nanodiscs, in the presence or absence of Mb38 megabody, was assessed using radioligand-binding assays. Modulation of 2 nM [ 3 H]flunitrazepam or [ 3 H]muscimol binding by varying concentrations of GABA or etomidate, respectively, was measured using wheat germ agglutinin-coated YSi scintillation proximity assay beads (SPA, PerkinElmer). Background binding was determined by displacement of [ 3 H]flunitrazepam or [ 3 H]muscimol with 100 μM diazepam or with 10 mM GABA respectively. Each reaction contained around 5 μg ml −1 purified receptor and 1 mg ml −1 SPA beads suspended in 10 mM HEPES pH 7.5 and 100 mM NaCl. Data normalization, graph preparation and nonlinear least squares curve fitting to a single-site binding model were performed in Igor Pro 7 (WaveMetrics).
Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
Atomic coordinates of the human α1β3γ2L GABA A receptor in complex with Mb38 have been deposited in the Protein Data Bank (PDB; accession code 6I53). The cryo-EM density maps have been deposited in the Electron Microscopy Data Bank (EMD-4411).
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Extended Data Fig. 6 | Vestibular glycans and interface classes in the α1β3γ2L GABA A receptor. a, Side view of the receptor shows the position of vestibular α1 N-linked glycans. For clarity, the near α1 and β3 subunits have been removed. b, View across the extracellular vestibule reveals the stacking of α1 N-linked glycans. The receptor surface is coloured according to electrostatic surface potential and reveals an electropositive ring in the middle portion of the ECD vestibule. c-f, Paired views of the interface between principle (+) and complementary (−) subunits viewed from the pore axis outwards (left) and open-book view of each subunit when viewed from the receptor periphery (right). Residues involved in forming interactions (defined using PDBePISA 45 ) are coloured according to the type of interaction and mapped onto the isosurface representation: polar, cyan; electrostatic/salt bridges, magenta; van der Waals, orange. Arrowheads reveal the openings of defined tunnels between adjacent subunits. g, Calculated interfacial buried surface areas and solvation energy gain at complex formation (both calculated using PDBePISA 44 ). The asterisk denotes the second β3/α1 (chain E/chain A) interface in the pentameric assembly. Radii of tunnels, denoted by arrowheads in c-f, were also calculated (see Methods). Open arrowheads in c, e denote cavities forming the proposed anaesthetic-binding sites.
Extended Data Fig. 7 | Disease mutations associated with α1, β3 and γ2, lateral tunnels and fenestrations at the subunit interfaces. a, b, Disease mutations associated with GABA A α1, β3 and γ2 subunits are mapped onto the structure and shown in sphere representation. The receptor is viewed parallel to the membrane plane (a) and from the extracellular aspect (b). Outlined boxes highlight the position of mutations shown in c-e. c-e, Close-up view of disease mutations associated with the α1 and β3 subunits. Polar interactions between residues are shown as dotted lines. f, Table summarizing several disease mutations identified in genes for α1, β3 and γ2. Functional effects as determined from experimental studies [52] [53] [54] [55] [56] [57] [58] of channel properties are summarized. g, Exposed surface of the γ2/β3 subunit interface coloured according to electrostatic surface potential. h, Close-up view of an electronegative fenestration formed at the γ2/β3 extracellular domain interface. The continuous tunnel leading from extracellular space to the receptor vestibule is outlined. i, Exposed surface of the α1/β3 subunit interface coloured according to electrostatic surface potential. j, Close-up view of the α1/β3 extracellular interface reveals an upper tunnel leading to the mid-portion of the ECD vestibule. A lower tunnel (denoted by the arrow) opens into the upper aspect of the ion channel at the level of β3His267, a residue that is implicated in mediating the effects of propofol 59 .
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